At the European Cell & Gene Therapy Summit 2025, funding challenges and innovation drove discussions on the sector’s future.

Thanks to in-utero blood transfusion technology, what was once a fatal diagnosis in the womb can now result in live births.

Exagamglogene autotemcel (exa-cel), a CRISPR/Cas9 gene-edited cell therapy, eliminated vaso-occlusive crises in 97% of ...

Bluebird bio has re-emerged after a private equity buyout as Genetix Biotherapeutics, marking a return to its roots and a new ...

Jesse Gelsinger died after receiving a gene therapy treatment to treat a liver disease. The death sparked an investigation ...

The drug, Yescarta, is reportedly sold in Singapore for about S$480,700. Read more at straitstimes.com. Read more at ...

Scientists from the Gray Faculty of Medical & Health Sciences at Tel Aviv University introduced an innovative gene therapy ...

A global leader in cell and gene therapy manufacturing recently planted its flag here in the Garden State. A number of company leaders, government officials, life sciences stakeholders and more were ...

Construction has begun on a new centre for gene and cell therapy in the German capital, Berlin. The "Translation Centre" will ...

In a preclinical study, researchers applied an innovative treatment approach for genetic hearing loss and found that it ...

IB [email protected] ScaleReady Awards G-Rex® Grants to Support Cell and Gene Therapy Manufacturing in California ST. PAUL, Minn., Sept. 9, 2025 - ScaleReady, in collaboration ...